DexCom, Inc. vs Snap Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Snap Inc trades at $5.49 (market cap $9.32B). The key difference: DexCom, Inc. is far larger — about 3.6× Snap Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Snap Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | SNAP | |
|---|---|---|
Market Cap | $33.79B | $9.32B |
Sector | Health | Media |
52-Week High | $89.53 | $9.09 |
52-Week Low | $54.84 | $3.93 |
Enterprise Value | $33.24B | $10.88B |
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →